Changeflow GovPing Pharma & Drug Safety MaxCyte Electroporation Device Design Patent US...
Routine Notice Added Final

MaxCyte Electroporation Device Design Patent USD1122471S1

Favicon for changeflow.com USPTO Patent Grants - Peptides (C07K)
Published
Detected
Email

Summary

The USPTO granted Design Patent USD1122471S1 to MaxCyte, Inc. for an electroporation device design. The patent application was filed on March 5, 2025, with inventors James William Luther, Bertold Engler, Andrea Besana, and Thomas Alan Peach. One design claim was granted. Design patents protect the ornamental appearance of a functional item for a term of 15 years from grant date.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO granted Design Patent USD1122471S1 for an electroporation device to MaxCyte, Inc. Design patents protect the ornamental appearance of a functional item rather than utilitarian features. The patent has a 15-year term from the grant date.

Affected parties include MaxCyte as the exclusive rights holder, competitors in the cell engineering and electroporation device market who should monitor for potential design patent infringement, and researchers or licensees who should verify their products do not infringe the protected ornamental design.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 15, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Electroporation device

Design USD1122471S1 Kind: S1 Apr 14, 2026

Assignee

MaxCyte, Inc.

Inventors

James William Luther, Bertold Engler, Andrea Besana, Thomas Alan Peach

CPC Classifications

B01D 57/02 C07K 1/26 C07K 1/24 B01L 3/0268 B01L 3/0275 B01L 3/5085 B01L 3/502707 B01L 9/52 G01N 27/447 G01N 27/44704 G01N 27/44756

Filing Date

2025-03-05

Application No.

29992017

Claims

1

View original document →

Get daily alerts for USPTO Patent Grants - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 14th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
USD1122471S1

Who this affects

Applies to
Medical device makers Technology companies Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent examination IP licensing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare Biotechnology

Get alerts for this source

We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!